Who
Robert Potashnick
CAO & VP of Finance
Company insider
Files Form 4 as: CAO & VP of Finance, Envoy Medical; Chief Financial Officer, FOXO Technologies.
In numbers
- Trades disclosed
- 14
- Buys
- 1
- Sells
- 0
- Bought
- $170K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 15 Sep 2022
- Last trade
- 24 Aug 2026
- Last filed
- 26 Aug 2026
Companies traded
Activity over time
1 Feb – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Aug 2026filed 26 Aug 2026 | COCH Envoy Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 24 Aug 2026filed 26 Aug 2026 | COCH Envoy Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | COCH Envoy MedicalMedical Devices | SEC FORM 4 Bought | $85K212,500 at $0.40 | filing |
| 12 Feb 2026filed 17 Feb 2026 | COCH Envoy Medicaloption or derivative · Medical Devices | SEC FORM 4 Code P | —127,500 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | COCH Envoy Medicaloption or derivative · Medical Devices | SEC FORM 4 Code P | —212,500 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | COCH Envoy Medicaloption or derivative · Medical Devices | SEC FORM 4 Code P | —127,500 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | COCH Envoy Medicaloption or derivative · Medical Devices | SEC FORM 4 Code P | —212,500 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | COCH Envoy MedicalMedical Devices | SEC FORM 4 Bought | $85K212,500 at $0.40 | filing |
| 5 Feb 2026filed 9 Feb 2026 | COCH Envoy Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 5 Feb 2026filed 9 Feb 2026 | COCH Envoy Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 15 Sep 2022filed 16 Sep 2022 | FOXO Technologiesoption or derivative · Life-science tools | SEC FORM 4 Code A | —78,413 at $0.00 | filing |
| 15 Sep 2022filed 16 Sep 2022 | FOXO Technologiesoption or derivative · Life-science tools | SEC FORM 4 Code A | —3,571 at $0.00 | filing |
| 15 Sep 2022filed 16 Sep 2022 | FOXO Technologiesoption or derivative · Life-science tools | SEC FORM 4 Code A | —2 at $0.00 | filing |
| 15 Sep 2022filed 16 Sep 2022 | FOXO TechnologiesLife-science tools | SEC FORM 4 Code A | —510,000 | filing |
News
DENTSPLY SIRONA (NASDAQ:XRAY) & Envoy Medical (NASDAQ:COCH) Financial AnalysisCOCH · tickerreport.com · 19 Oct 2026Contrasting Biomerica (NASDAQ:BMRA) and Envoy Medical (NASDAQ:COCH)COCH · themarketsdaily.com · 19 Oct 2026Financial Survey: RxSight (NASDAQ:RXST) versus Envoy Medical (NASDAQ:COCH)COCH · themarketsdaily.com · 11 Oct 2026
0 headlines in the last 90 days name Robert Potashnick; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.